期刊文献+

克罗恩病患者血清25-羟基维生素D水平与炎性细胞因子的关系 被引量:1

Relationship between Serum 25-hydroxy-vitamin D and Inflammatory Cytokines Levels in Patients with Crohn's Disease
下载PDF
导出
摘要 目的探讨缓解期克罗恩病患者血清25-羟基维生素D与炎性细胞因子白细胞介素-10(interleukin-10,IL-10)及肿瘤坏死因子-α(tumour necrosis factor-α,TNF-α)的关系。方法根据血清维生素D水平将35例缓解期克罗恩病患者分为维生素D缺乏组(A组)和维生素D充足组(B组),采用ELISA检测两组患者入组时及A组患者经补充维生素D治疗后的血清IL-10和TNF-α水平。结果 A、B两组患者血清TNF-α水平比较无统计学差异(P>0.05),A组患者血清IL-10水平显著低于B组(P<0.05);A组患者经补充维生素D治疗后血清IL-10和TNF-α水平与治疗前比较无统计学差异(P>0.05)。结论存在维生素D缺乏的克罗恩病患者循环IL-10水平显著降低,提示维生素D缺乏可能与这些患者的抗炎能力下降有关。 Objective To determine if serum 25-hydroxy-vitamin D was associated with inflammatory cytokines, interleukin-10 (IL-10), and tumour necrosis factor-α(TNF-α) levels in patients with inactive Crohn’s disease (CD). Methods 35 adults with quiescent CD were divided into vitamin D-insufifcient group (group A) and vitamin D-replete group (group B) according to serum 25-hydroxy-vitamin D levels. Then serum IL-10 and TNF-αlevel were detected by ELISA and compared. After vitamin D supplement to patients in group A, serum IL-10 and TNF-αlevels were detected again and compared to previous levels. Result Serum IL-10 levels of patients in group A were signiifcantly lower compared with group B (P〈0.05) while there were no differences in serum TNF-αlevels (P〉0.05). The use of a vitamin D supplement did not signiifcantly inlfuence serum IL-10 and TNF-αlevel (P〉0.05). Conclusions Circulating levels of IL-10, but not TNF-alpha, were signiifcantly lower in CD patients with inadequate serum 25-hydroxy-vitamin D. This suggests that poor vitamin D status may be linked to reduced anti-inlfammatory capacity in these
出处 《中国医药指南》 2013年第25期330-332,共3页 Guide of China Medicine
关键词 克罗恩病 25-羟基维生素D 白细胞介素-10 肿瘤坏死因子-Α Crohn's disease 25-hydroxy-vitamin D Interleukin-10 Tumour necrosis factor-α
  • 相关文献

参考文献13

  • 1Kornbluth A,Hayes M,Feldman S,et al.Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria[J].Am J Gastroenterol,2006,101(7): 1546-1550. 被引量:1
  • 2Scott EM,Gaywood I,Scott BB.Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease.British Society of Gastroenterology[J].Gut,2000,46(Suppl 1):il-8. 被引量:1
  • 3Cantorna MT, Zhu Y, Froicu M,et al.Vitamin D status, l,25-dihydr- oxyvitamin D3,and the immune system[J].Am J Clin Nutr,2004,80 (6 Suppl): 1717S-1720S. 被引量:1
  • 4Froicu M,Weaver V, Wyrm TA,et al.A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases[J].Mol Endocrinol,2003,17( 12):2386-2392. 被引量:1
  • 5Cantorna MT, Munsick C,Bemiss C,et al.l,25-Dihydroxyeholec- alciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease[J].J Nutr,2000,130(11): 2648-2652. 被引量:1
  • 6Zhu Y, Mahon BD,Froieu M,et al.Calcium and 1 alpha,25-dihyd-roxyvitamin D3 target the TNF-alpha pathway to suppress exper- imental inflammatory bowel disease[J].Eur J Immunol 2005,35 (1):217-224. 被引量:1
  • 7Barrels LE,Jorgensen SP, Agnholt J,et al.l,25-dihydroxyvitamin Da and dexamethasone increase interleukin-10 production in CD4- T cells from patients with Crohn's disease[J].Int Immunopharma- col 2007,7(13): 1755-1764. 被引量:1
  • 8Loftus EV Jr.Clinical epidemiology of inflammatory bowel disease:Incidence,prevalence,and environmental influences[J]. Gastroenterology 2004,126(6): 1504-1517. 被引量:1
  • 9Naderi N,Farnood A,Habibi M,et al.Association of vitamin D receptor gene polymorphisms in Iranian patients with inflamma- tory bowel disease [J].J Gastroenterol Hepatol 2008,23(12): 1816-1822. 被引量:1
  • 10Jorgensen SP, Agnholt J,Glerup H,et al.Clinical trial:vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo- controlled smdy[J].Aliment Pharmacol Ther,2010,32(3):377-383. 被引量:1

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部